European Medicines Agency - Regulatory - Regulation of medicines

3 - Specific competencies and capacity to provide export advice



    Description

Name

 

ReSViNET - Respiratory Syncytial Virus Network

Number of peer reviewed publications in the last 5 years 4 “Development and Validation of a New Clinical Scale for Infants with Acute Respiratory Infection: The ReSVinet Scale” PLOS ONE 2016 “Meeting Report: Harmonization of RSV therapeutics – from design to performance” Journal of Global Health 2016 “Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics” Lancet Respiratory Medicine 2015 “RSV—Still More Questions Than Answers” The Pediatric Infectious Disease Journal 2014
Number of competitive grants obtained in the last 5 years 2
Access to expert groups Yes
Capacity to answer external scientific questions Yes
Site feasibility Yes
Participant recruitment Yes this is present and provided by the sites
Budget calculation for studies Yes